Pharma Rights Transfer Sinks Tax Deficiency, 3rd Circ. Told

By Jeannie O'Sullivan (October 10, 2017, 3:54 PM EDT) -- Hygrosol Pharmaceutical Corp.'s co-founder on Tuesday urged a Third Circuit panel to vacate a $5.8 million federal tax debt imposed on him after the IRS found he wrongly wrote off royalties on technology he developed as capital gains instead of ordinary income, arguing that he no longer owned the technology since he'd signed away the rights to it....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!